ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2023

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 7,677$196,1470.28%
Hennion & Walsh Asset Management, Inc. 54,598$1,394,9790.09%
Formidable Asset Management, LLC 15,050$384,5280.08%
Byrne Asset Management LLC 3,270$84,0000.07%
Virtu Financial LLC 23,445$5990.06%
Virtus ETF Advisers LLC 3,582$91,5200.06%
JUPITER ASSET MANAGEMENT LTD 194,781$4,976,6550.06%
DARK FOREST CAPITAL MANAGEMENT LP 25,228$644,5750.05%
MGO ONE SEVEN LLC 23,688$605,2280.05%
Koss-Olinger Consulting, LLC 9,300$238,0000.04%
External links

This page lists ARCTURUS THERAPEUTICS HLDGS's shareholders in Q3 2023. To view ARCTURUS THERAPEUTICS HLDGS's shareholder history, click here.